C Difficile

9693 bookmarks
Newest
Sugar-rich foods exacerbate antibiotic-induced microbiome injury - PubMed
Sugar-rich foods exacerbate antibiotic-induced microbiome injury - PubMed
Intestinal microbiota composition is implicated in several diseases; understanding the factors that influence it are key to elucidating host-commensal interactions and to designing microbiome-targeted therapies. We quantified how diet influences microbiome dynamics in hospitalized patients. We recor …
·pubmed.ncbi.nlm.nih.gov·
Sugar-rich foods exacerbate antibiotic-induced microbiome injury - PubMed
Microbiota Transplantation in Individuals with Type 2 Diabetes and a High Degree of Insulin Resistance - PubMed
Microbiota Transplantation in Individuals with Type 2 Diabetes and a High Degree of Insulin Resistance - PubMed
The objective of this study was to determine the results of fecal microbiota transplantation (FMT) from healthy lean subjects in patients with type 2 diabetes (T2D); Methods: We designed a phase II, randomized, single-blind, parallel-arm clinical trial. Twenty-one subjects (12 men [57.1%] and 9 wome …
·pubmed.ncbi.nlm.nih.gov·
Microbiota Transplantation in Individuals with Type 2 Diabetes and a High Degree of Insulin Resistance - PubMed
Nutritional and Microbial Strategies for Treating Acne, Alopecia, and Atopic Dermatitis - PubMed
Nutritional and Microbial Strategies for Treating Acne, Alopecia, and Atopic Dermatitis - PubMed
Consuming a healthy, plant-based diet can reduce skin inflammation and enhance overall skin health. Although the application of probiotics, synbiotics, and postbiotics has demonstrated promise in modulating inflammation, enhancing tissue regeneration, and inhibiting pathogenic colonization, further …
·pubmed.ncbi.nlm.nih.gov·
Nutritional and Microbial Strategies for Treating Acne, Alopecia, and Atopic Dermatitis - PubMed
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut-Lung Axis and Therapeutic Approaches - PubMed
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut-Lung Axis and Therapeutic Approaches - PubMed
The human gut microbiota is a complex ecosystem harboring thousands of microbial strains that play a crucial role in maintaining the overall well-being of its host. The composition of the gut microbiota varies with age from infancy to adulthood and is influenced by dietary habits, environment, and g …
·pubmed.ncbi.nlm.nih.gov·
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut-Lung Axis and Therapeutic Approaches - PubMed
The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings - PubMed
The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings - PubMed
The gut microbiota is a pivotal factor in AD pathogenesis, influencing neuroinflammation and disease progression. Understanding the role of gut microbiota in AD opens avenues for innovative diagnostic, preventive, and therapeutic strategies.
·pubmed.ncbi.nlm.nih.gov·
The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings - PubMed
Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications-A Literature Review - PubMed
Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications-A Literature Review - PubMed
Emerging evidence highlights the crucial role of gastrointestinal microbiota in the pathogenesis of gastric cancer. Helicobacter pylori (H. pylori) infection stands out as a primary pathogenic factor. However, interventions such as anti-H. pylori therapy, gastric surgeries, immu …
·pubmed.ncbi.nlm.nih.gov·
Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications-A Literature Review - PubMed
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases - PubMed
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases - PubMed
The gut microbiome emerges as an integral component of precision medicine because of its signature variability among individuals and its plasticity, which enables personalized therapeutic interventions, especially when integrated with other multiomics data. This promise is further fueled by advances …
·pubmed.ncbi.nlm.nih.gov·
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases - PubMed
Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease - PubMed
Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease - PubMed
Over the past decade, there has been a rapid increase in the incidence of inflammatory bowel disease. It has been suggested that multifactorial interactions of environmental factors, genetic factors, immune response and intestinal microbiota are involved in the pathogenesis of inflammatory bowel dis …
·pubmed.ncbi.nlm.nih.gov·
Targeting the Intestinal Microbiota: A Novel Direction in the Treatment of Inflammatory Bowel Disease - PubMed
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy - PubMed
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy - PubMed
Sepsis is a complex clinical syndrome characterized by an uncontrolled inflammatory response to an infection that may result in septic shock and death. Recent research has revealed a crucial link between sepsis and alterations in the gut microbiota, showing that the microbiome could serve an essenti …
·pubmed.ncbi.nlm.nih.gov·
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy - PubMed
A Mouse Model of Mild Clostridioides difficile Infection for the Characterization of Natural Immune Responses - PubMed
A Mouse Model of Mild Clostridioides difficile Infection for the Characterization of Natural Immune Responses - PubMed
(1) Background: We describe a model of primary mild-Clostridioides difficile infection (CDI) in a naïve host, including gut microbiota analysis, weight loss, mortality, length of colonization. This model was used in order to describe the kinetics of humoral (IgG, IgM) and mucosal (IgA) immune …
·pubmed.ncbi.nlm.nih.gov·
A Mouse Model of Mild Clostridioides difficile Infection for the Characterization of Natural Immune Responses - PubMed
Bausch Health Companies Inc. (NASDAQ:BHC) | ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Bausch Health Companies Inc. (NASDAQ:BHC) | ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Bausch Health's additional ACG presentation to focus on Xifaxan impact on OHE rehospitalizations and Plenvu bowel preparation efficacy at ACG 2024. Posters to share findings on treatments
·webdisclosure.com·
Bausch Health Companies Inc. (NASDAQ:BHC) | ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
[Gut Microbiota as a Potential Biomarker for Immune Checkpoint Inhibitors] - PubMed
[Gut Microbiota as a Potential Biomarker for Immune Checkpoint Inhibitors] - PubMed
Immune checkpoint inhibitors(ICIs)currently play a predominant role in the standard treatment of non-small cell lung cancer(NSCLC)across all stages. While PD-L1 positivity has traditionally been used as the sole effective biomarker, evidence suggests that certain efficacy exists even in PD-L1-negati …
·pubmed.ncbi.nlm.nih.gov·
[Gut Microbiota as a Potential Biomarker for Immune Checkpoint Inhibitors] - PubMed
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report - PubMed
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report - PubMed
Clostridioides difficile infection (CDI) is generally treated with vancomycin, metronidazole or fidaxomicin, although fecal microbiota transplantation (FMT) represents a promising therapeutic option for antibiotic-resistant recurrent C. difficile infections (rCDIs) in adults. In pediat …
·pubmed.ncbi.nlm.nih.gov·
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report - PubMed
Improved health-related quality of life in patients with recurrent Clostridioides difficile infection after treatment with faecal microbiota transplantation - PubMed
Improved health-related quality of life in patients with recurrent Clostridioides difficile infection after treatment with faecal microbiota transplantation - PubMed
Since FMT cures, reduces the risk of new recurrences of CDI and improves the HRQoL of the patients, it should be offered as a treatment for patients with rCDI. Also, SHS is a useful and reliable instrument for measuring HRQoL in patients with rCDI.
·pubmed.ncbi.nlm.nih.gov·
Improved health-related quality of life in patients with recurrent Clostridioides difficile infection after treatment with faecal microbiota transplantation - PubMed
Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study - PubMed
Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study - PubMed
Recurrent CDI occurred in 10% of HCT recipients in the early posttransplant period and was associated with use of metronidazole. Further study is needed to characterize risk factors for recurrent CDI among HCT recipients to guide use of agents aimed at preventing recurrence.
·pubmed.ncbi.nlm.nih.gov·
Epidemiology and Outcomes of Recurrent C Difficile Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study - PubMed
Angelica sinensis Polysaccharide Alleviates Staphylococcus aureus-Induced Mastitis by Regulating The Intestinal Flora and Gut Metabolites - PubMed
Angelica sinensis Polysaccharide Alleviates Staphylococcus aureus-Induced Mastitis by Regulating The Intestinal Flora and Gut Metabolites - PubMed
The modulation of intestinal flora by various polysaccharides has been shown to mitigate disease progression. Recent research reveals a significant link between intestinal flora and the progression of mastitis. This study demonstrates that the oral administration of Angelica sinensis polysacc …
·pubmed.ncbi.nlm.nih.gov·
Angelica sinensis Polysaccharide Alleviates Staphylococcus aureus-Induced Mastitis by Regulating The Intestinal Flora and Gut Metabolites - PubMed
Gut-first Parkinson's disease is encoded by gut dysbiome - PubMed
Gut-first Parkinson's disease is encoded by gut dysbiome - PubMed
We propose that the dysbiotic gut microbiome (dysbiome) in PD can disrupt a healthy microbiome and Th17 homeostatic immunity in the ileum mucosa, leading to a cascade effect that propagates to the brain, ultimately contributing to PD pathophysiology. Our landmark study has successfully identified ne …
·pubmed.ncbi.nlm.nih.gov·
Gut-first Parkinson's disease is encoded by gut dysbiome - PubMed
Ellagic acid ameliorates alcohol-induced cognitive and social dysfunction through the gut microbiota-mediated CCL21-CCR7 axis - PubMed
Ellagic acid ameliorates alcohol-induced cognitive and social dysfunction through the gut microbiota-mediated CCL21-CCR7 axis - PubMed
Chronic alcohol consumption disrupts the balance of the gut microbiome, resulting in alcohol-induced cognitive and social dysfunction (AICSD), and serves as a primary etiological factor for early-onset dementia. Ellagic acid (EA) is a polyphenolic compound belonging to the ellagitannin family, showi …
·pubmed.ncbi.nlm.nih.gov·
Ellagic acid ameliorates alcohol-induced cognitive and social dysfunction through the gut microbiota-mediated CCL21-CCR7 axis - PubMed
Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections - PubMed
Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections - PubMed
Clostridioides difficile is a major causative pathogen for antibiotic-associated diarrhea and C. difficile infections (CDIs) may lead to life-threatening diseases in clinical settings. Most of the risk factors for the incidence of CDIs, i.e., antibiotic use, treatment by proton pump in …
·pubmed.ncbi.nlm.nih.gov·
Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections - PubMed
The Impact of Clinical Pharmacist-Driven Weekend Antimicrobial Stewardship Coverage at a Quaternary Hospital - PubMed
The Impact of Clinical Pharmacist-Driven Weekend Antimicrobial Stewardship Coverage at a Quaternary Hospital - PubMed
The pharmacist-driven weekend AMS is an opportunity for pharmacists to intervene and optimize patients' care plans. This initiative demonstrated significant increased AMS-related interventions, promoted judicious antimicrobial use, and contributed to a reduced length of hospital stay. Our findings n …
·pubmed.ncbi.nlm.nih.gov·
The Impact of Clinical Pharmacist-Driven Weekend Antimicrobial Stewardship Coverage at a Quaternary Hospital - PubMed
Do Probiotics Work?
Do Probiotics Work?
In some cases, yes, but there’s still much that experts have yet to learn about how these microscopic organisms work.
·healthcentral.com·
Do Probiotics Work?
Fecal Microbiota Transplantation Outcome and Gut Microbiota Composition in Ulcerative Colitis: a Systematic Review and Meta-analysis - PubMed
Fecal Microbiota Transplantation Outcome and Gut Microbiota Composition in Ulcerative Colitis: a Systematic Review and Meta-analysis - PubMed
This systematic review/meta-analysis yielded a coherent picture from a compositional perspective, which may help identify beneficial donor profiles and guide personalized FMT approaches.
·pubmed.ncbi.nlm.nih.gov·
Fecal Microbiota Transplantation Outcome and Gut Microbiota Composition in Ulcerative Colitis: a Systematic Review and Meta-analysis - PubMed
Total alkaloids of Aconitum carmichaelii Debx alleviate cisplatin-induced acute renal injury by inhibiting inflammation and oxidative stress related to gut microbiota metabolism - PubMed
Total alkaloids of Aconitum carmichaelii Debx alleviate cisplatin-induced acute renal injury by inhibiting inflammation and oxidative stress related to gut microbiota metabolism - PubMed
ACA protects against cisplatin-induced AKI through its anti-inflammatory and antioxidant functions, which may be associated with the restoration of gut microbiota metabolism. ACA is a potential drug for AKI and other forms of organ damage related to the disruption of the gut microbiota.
·pubmed.ncbi.nlm.nih.gov·
Total alkaloids of Aconitum carmichaelii Debx alleviate cisplatin-induced acute renal injury by inhibiting inflammation and oxidative stress related to gut microbiota metabolism - PubMed